← DPT/Polio/Haemophilus Type B Vaccine

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

DPT/Polio/Haemophilus Type B Vaccine

Vaccine / immunological product

Prepared 19 Sep 2026

What it is used for

Therapeutic use is agent- and indication-specific within the class (Vaccine / immunological product). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.

Warnings

[DPT] Observe 15 minutes post-dose if high anaphylaxis concern. Correct injection technique and site. Report AEFI via national systems. [Haemophilus Type B Vaccine] Observe 15 minutes post-dose if high anaphylaxis concern. Correct injection technique and site. Report AEFI via national systems.

Possible side effects

[DPT] Local pain, low-grade fever, myalgia. Serious: anaphylaxis, vaccine-specific rare events (e.g. intussusception historically with some rotavirus products). [Haemophilus Type B Vaccine] Local pain, low-grade fever, myalgia. Serious: anaphylaxis, vaccine-specific rare events (e.g. intussusception historically with some rotavirus products).

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage